- Revenue of $261 million, GAAP Net Loss Per Share of $(0.39),
Non-GAAP Net Loss Per Share of $(0.12)
- GAAP and Non-GAAP gross margins expand driven by 102%
year-over-year growth in Fitbit.com sales
Fitbit, Inc. (NYSE:FIT) today reported revenue of $261 million,
GAAP net loss per share of $(0.39), non-GAAP net loss per share of
$(0.12), GAAP net loss of $(104) million, non-GAAP net loss of
$(32) million, cash flow from operations of $33 million, and
non-GAAP free cash flow of $28 million for its second quarter of
2020.
“We have been focused on helping our community stay physically
active and mentally well during the pandemic. In this uncertain
COVID-19 environment, we are seeing consumers turn to options that
enable them to take charge of their health, such as Fitbit devices.
In addition, many customers have taken advantage of Fitbit’s free
premium trial offering and signed up for our subscription service,”
said James Park, co-founder and CEO. “While COVID-19 has impacted
our business and there continues to be uncertainty around consumer
demand and the economy, we are encouraged by the 12% year-over-year
POS sales growth we’ve seen at retail and through Fitbit.com.”
Second Quarter 2020 Financial
Summary
For the Three Months
Ended
For the Six Months
Ended
In millions, except percentages and per
share amounts
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
GAAP Results
Revenue
$
261.3
$
313.6
$
449.4
$
585.4
Gross Margin
35.6
%
34.5
%
32.9
%
33.8
%
Net loss
$
(104.1)
$
(68.5)
$
(83.8)
$
(148.0)
Net loss Per Share
$
(0.39)
$
(0.27)
$
(0.31)
$
(0.58)
Non-GAAP Results
Gross Margin
37.6
%
35.6
%
35.2
%
34.9
%
Net loss
$
(31.5)
$
(35.8)
$
(96.1)
$
(73.8)
Net loss Per Share
$
(0.12)
$
(0.14)
$
(0.36)
$
(0.29)
Adjusted EBITDA
$
(31.8)
$
(30.8)
$
(107.3)
$
(74.0)
Devices Sold
2.5
3.5
4.6
6.5
For additional information regarding the non-GAAP financial
measures, see “Non-GAAP Financial Measures” and “Reconciliation of
GAAP to Non-GAAP Financial Measures” below.
Second Quarter 2020 Financial Highlights
- Sold 2.5 million devices, down 30% year-over-year, driven by
the introduction of one new product in the first half of 2020
versus four new products in the first half of 2019. Average selling
price increased 16% year-over-year to $100 per device. The
year-over-year price increase was driven primarily by the higher
percentage of sales through the Fitbit.com channel, which grew 102%
year-over-year to $66 million of sales.
- U.S. revenue represented 63% of total revenue or $165 million,
down 9% year-over-year.
- International revenue represented 37% of total revenue and
declined 27% to $97 million: EMEA revenue declined 17% to $72
million, APAC revenue declined 47% to $14 million and Americas
excluding U.S. revenue declined 45% to $10 million, (all on a
year-over-year basis).
- New devices introduced in the past 12 months, Fitbit Charge 4™,
Fitbit Versa 2™, and Fitbit Aria Air™, represented 71% of
revenue.
- GAAP gross margin was 35.6% and non-GAAP gross margin was
37.6%. GAAP gross margin increased 120 basis points and non-GAAP
gross margin increased 200 basis points year-over-year driven by
higher average selling price, the mix shift to Fitbit.com and
growth of premium revenue, as well as $9 million decrease in excess
and obsolete inventory write-downs.
- GAAP operating expenses represented 70.5% of revenue,
increasing 3% year-over-year to $184 million driven by costs
related to the pending acquisition by Google LLC; non-GAAP
operating expenses represented 54.6% of revenue, decreasing 11%
year-over-year to $143 million driven by lower marketing costs and
lower customer service costs.
Second Quarter 2020 Operational Highlights
- Consumer demand for Fitbit devices was strong in the second
quarter with POS up 12% in the second quarter. This was driven by
34% growth in smartwatch sales, led by sales of Versa 2.
- Revenue lagged POS sales driven by a large reduction in channel
inventory. Global inventory in the channel declined by
approximately one million units.
- Smartwatches represented 40% of revenue, trackers represented
56% of revenue and non-device software offerings were 4% of
revenue. Tracker sales benefited from the introduction of Charge 4
in the first quarter of 2020. Non-device revenue grew 195%
year-over-year driven by the growth of our consumer premium health
offering.
- Following the introduction in the first quarter of 2020 of a
90-day free trial offering of Fitbit Premium to give users more
tools to stay healthy during COVID-19, we began to see healthy
levels of conversion from free to paid users. Fitbit ranked as a
top 10 paid app within the Health & Fitness category on both
Google Play and the iOS Store in the United States in the second
quarter and now ranks as the number one paid app in the U.S. in
Google Play and top five in the iOS store.
- Our Fitbit Health Solutions business was negatively impacted by
COVID-19 and represented 7% of revenue, or $17 million.
- We introduced a COVID-19 resource tab in our free app that
provides access to helpful information, tools, and resources, such
as connecting with a doctor virtually.
- We announced a broader research effort in coordination with
health industry leaders like Stanford Medicine and The Scripps
Research Institute, to study how data from wearables can detect,
track, and contain infectious diseases like COVID-19.
- We developed a high-quality, low-cost, easy to use emergency
ventilator, Fitbit Flow, which has obtained Emergency Use
Authorization from the U.S. Food and Drug Administration, to help
address urgent global needs during COVID-19.
COVID-19-Related Impact to Financials
- Our business during the second quarter of 2020 was negatively
impacted by the outbreak of COVID-19, which has caused disruptions
in the development, manufacture, shipment, and sales of our
products.
- We maintained the COVID-19 credit allowance of $6 million
during the second quarter of 2020.
- The current circumstances are dynamic and unprecedented, and
the impacts of COVID-19 on our business operations, including the
duration and severity of the effect on overall consumer demand,
cannot be predicted. However, we expect COVID-19 and associated
mitigation efforts to continue to have a significant negative
impact on our results in 2020, including our liquidity, although
the nature and extent will depend on future developments that are
evolving and highly uncertain.
Additional Highlights and Information
- Fitbit announced its entry into a Merger Agreement with Google
on November 1, 2019. Upon close of the all-cash transaction, which
is subject to customary closing conditions, Fitbit stockholders
will receive $7.35 per share in cash, valuing the company at a
fully diluted equity value of approximately $2.1 billion.
- Fitbit stockholders approved the transaction on January 3,
2020.
- Regulatory review of the transaction is ongoing. On August 4,
2020, the European Commission announced it has initiated a Phase II
review of the transaction. The duration of a Phase II review cannot
be foreseen with certainty. While we still expect Fitbit and Google
to secure the necessary regulatory approvals and to close the
transaction in 2020, the time frame may extend beyond that.
Moreover, the extent to which COVID-19 may impact the timing of
receipt of these approvals is uncertain and cannot be predicted.
Prior to closing, we do not expect to provide additional updates on
the regulatory process other than during the release of future
earnings reports.
- Due to the pending acquisition by Google, Fitbit does not plan
to host an earnings conference call nor provide next-quarter or
full-year guidance.
Forward Looking Statements
This press release contains “forward-looking” statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, that involve risks and uncertainties. In some cases, you
can identify these forward-looking statements by the use of terms
such as “expect,” “will,” “continue,” or similar expressions, and
variations or negatives of these words, but the absence of these
words does not mean that a statement is not forward-looking. All
statements other than statements of historical fact could be deemed
forward-looking statements, including, but not limited to: our
ability to develop innovative products and services that can help
people during the COVID-19 pandemic; any statements regarding the
anticipated impact of COVID-19 on our business; the expected timing
of the completion of the transaction with Google; the ability of
Google and us to complete the proposed transaction considering the
various conditions to the transaction, some of which are outside
the parties’ control, including those conditions related to
regulatory approvals; any statements concerning the expected
development or competitive performance relating to Fitbit’s
products and services; and any statements of assumptions underlying
any of the foregoing. A number of important factors and
uncertainties could cause actual results or events to differ
materially from those described in these forward-looking
statements, including without limitation: the impact of COVID-19 on
our business, results of operations, or financial condition,
including the development, manufacturing, and shipment of our
products; general public health, market, political, economic and
business conditions, including the impact of COVID-19 on global
economic conditions and consumer confidence and spending; the
effects of the highly competitive market in which we operate,
including competition from much larger technology companies; our
ability to anticipate and satisfy consumer preferences in a timely
and cost-effective manner; our ability to successfully develop,
timely introduce, and achieve retail and customer acceptance of new
products and services, or enhance existing products and services,
including software and subscription services; our ability to
accurately forecast consumer demand and adequately manage our
inventory; our ability to ship products on the timelines we
anticipate and avoid unexpected delays; our ability to detect,
prevent or fix quality issues in our products and services; our
ability to attract and retain employees; our reliance on
third-party suppliers, contract manufacturers, and logistics
providers and our limited control over such parties; delays in
procuring components and products from third parties or their
suppliers; the ability of third parties to manufacture and ship
quality products in a timely manner; seasonality of demand; the
concentrated nature of our retailer and distributor base; product
liability issues, security breaches, or other factors that may
adversely affect product performance and overall market acceptance
of our products and services; our ability to integrate acquired
technologies and employees of acquired businesses into our
operations, particularly in new geographies; warranty claims; the
relatively new and unproven market for trackers and wearable
devices; the ability of our channel partners to sell our products;
litigation and related costs; the impact of privacy and data
security laws; changes in tax laws; the impact of tariffs; the
failure to satisfy any of the conditions to the consummation of the
proposed transaction with Google, including the receipt of certain
governmental and regulatory approvals; the occurrence of any event,
change, or other circumstance that could give rise to the
termination of the Merger Agreement; the outcome of any legal
proceedings that may be instituted against us related to the Merger
Agreement or the proposed transaction; unexpected costs, charges or
expenses resulting from the proposed transaction; the occurrence of
a Company Material Adverse Effect (as defined in the Merger
Agreement).
Additional risks and uncertainties are included under the
caption “Risk Factors” in our Annual Report on Form 10-K for the
full year ended December 31, 2019, and our Quarterly Report Form
10-Q for the three months ended April 4, 2020, which are available
on our Investor Relations website at investor.fitbit.com and on the
Security Exchange Commission (SEC) website at www.sec.gov. Once
filed with the SEC, additional information will be set forth in our
Quarterly Report on Form 10-Q for the three months ended July 4,
2020. All forward-looking statements contained herein are based on
information available to us as of the date hereof and we do not
assume any obligation to update these statements as a result of new
information or future events. We may not actually achieve the
plans, intentions, or expectations disclosed in our forward-looking
statements and you should not place undue reliance on such
statements.
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are
prepared and presented in accordance with GAAP, we use the
following non-GAAP financial measures in this press release:
non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating
expenses, non-GAAP operating loss, non-GAAP operating loss before
income taxes, non-GAAP net income (loss), non-GAAP basic/diluted
net income (loss) per share, free cash flow, non-GAAP research and
development expenses, non-GAAP sales and marketing expenses,
non-GAAP general and administrative expenses, and adjusted EBITDA.
The presentation of these financial measures is not intended to be
considered in isolation or as a substitute for, or superior to,
financial information prepared and presented in accordance with
GAAP.
We use non-GAAP measures to internally evaluate and analyze
financial results. We believe these non-GAAP financial measures
provide investors with useful supplemental information about the
financial performance of our business, enable comparison of
financial results between periods where certain items may vary
independent of business performance, and enable comparison of our
financial results with other public companies, many of which
present similar non-GAAP financial measures.
There are limitations associated with the use of non-GAAP
financial measures as an analytical tool. In particular, many of
the adjustments to our GAAP financial measures reflect the
exclusion of certain items, specifically stock-based compensation
expense, depreciation, amortization of intangible assets, interest
income, net, acquisition-related costs, and the related income tax
effects of the aforementioned exclusions, that are recurring and
will be reflected in our financial results for the foreseeable
future. In addition, these measures may be different from non-GAAP
financial measures used by other companies, limiting their
usefulness for comparison purposes. A reconciliation of our
non-GAAP financial measures to their most directly comparable GAAP
measures has been provided in the financial statement tables
included in this press release, and investors are encouraged to
review the reconciliation.
The following are explanations of the adjustments that are
reflected in one or more of our non-GAAP financial measures:
- Stock-based compensation expense relates to equity awards
granted primarily to our employees. We exclude stock-based
compensation expense because we believe that the non-GAAP financial
measures excluding this item provide meaningful supplemental
information regarding operational performance. Companies calculate
stock-based compensation expense using a variety of valuation
methodologies and subjective assumptions.
- Acquisition-related costs relates to bonuses in connection with
the Merger, integration costs, advisory and consulting, legal,
accounting, tax, other professional service fees, and SEC filing
fees to the extent associated with the pending Merger or our
acquisition of other companies.
- Restructuring costs primarily included severance-related costs.
We believe that excluding this expense provides greater visibility
to the underlying performance of our business operations,
facilitates comparison of our results with other periods, and may
also facilitate comparison with the results of other companies in
our industry.
- Amortization of intangible assets relates to our acquisitions
of FitStar, Pebble, Vector and Twine Health. We exclude these
amortization expenses because we do not believe they have a direct
correlation to the operation of our business.
- Income tax effect of non-GAAP adjustments relates to the tax
effect of the adjustments that we incorporate into non-GAAP
financial measures such as stock-based compensation, amortization
of intangibles, restructuring and valuation allowance in order to
provide a more meaningful measure of non-GAAP net loss.
- We define free cash flow as net cash provided by (used in)
operating activities less purchase of property and equipment. We
consider free cash flow to be a liquidity measure that provides
useful information to management and investors about the amount of
cash generated by the business that can possibly be used for
investing in our business and strengthening the balance sheet, but
it is not intended to represent the residual cash flow available
for discretionary expenditures. Free cash flow is not prepared in
accordance with U.S. GAAP, and should not be considered in
isolation of, or as an alternative to, measures prepared in
accordance with U.S. GAAP.
About Fitbit, Inc. (NYSE: FIT)
Fitbit helps people lead healthier, more active lives by
empowering them with data, inspiration, and guidance to reach their
goals. Fitbit designs products and experiences that track and
provide motivation for everyday health and fitness. Fitbit’s
diverse line of innovative and popular products include Fitbit
Charge 4™, Fitbit Charge 3™, Fitbit Inspire HR™, Fitbit Inspire™,
and Fitbit Ace 2™ activity trackers, as well as the Fitbit Ionic™
and Fitbit Versa™ family of smartwatches, Fitbit Flyer™ wireless
headphones, and Fitbit Aria™ family of connected scales. Fitbit
products are carried in over 39,000 retail stores and in over 100
countries around the globe. Powered by one of the world’s largest
health and fitness social networks and databases of health and
fitness data, the Fitbit platform delivers personalized
experiences, insights and guidance through leading software and
interactive tools, including the Fitbit and Fitbit Coach apps, and
Fitbit OS for smartwatches. Fitbit Health Solutions develops health
and wellness solutions designed to help increase engagement,
improve health outcomes, and drive a positive return for employers,
health plans and health systems.
Fitbit and the Fitbit logo are trademarks or registered
trademarks of Fitbit, Inc. in the United States, and other
countries. Additional Fitbit trademarks can be found at
www.fitbit.com/legal/trademark-list. Third-party trademarks are the
property of their respective owners.
Connect with us on Facebook, Instagram and Twitter and share
your Fitbit experience
FITBIT, INC.
Condensed Consolidated
Statements of Operations
(in thousands, except per share
amounts)
(unaudited)
Three Months Ended
Six Months Ended
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
Revenue
$
261,272
$
313,556
$
449,430
$
585,446
Cost of revenue
168,230
205,342
301,466
387,779
Gross profit
93,042
108,214
147,964
197,667
Operating expenses:
Research and development
83,733
70,919
165,322
147,958
Sales and marketing
65,470
83,060
122,431
151,676
General and administrative
35,049
24,865
77,090
51,557
Total operating expenses
184,252
178,844
364,843
351,191
Operating loss
(91,210)
(70,630)
(216,879)
(153,524)
Interest income, net
13
2,622
1,306
6,088
Other income, net
2,237
461
2,233
1,734
Loss before income taxes
(88,960)
(67,547)
(213,340)
(145,702)
Income tax expense (benefit)
15,137
971
(129,537)
2,281
Net loss
$
(104,097)
$
(68,518)
$
(83,803)
$
(147,983)
Net loss per share:
Basic
$
(0.39)
$
(0.27)
$
(0.31)
$
(0.58)
Diluted
$
(0.39)
$
(0.27)
$
(0.31)
$
(0.58)
Shares used to compute net loss per
share:
Basic
267,872
256,160
266,742
254,659
Diluted
267,872
256,160
266,742
254,659
FITBIT, INC.
Condensed Consolidated Balance
Sheets
(in thousands)
(unaudited)
July 4, 2020 December 31, 2019
Assets
Current assets:
Cash and cash equivalents
$
343,476
$
334,479
Marketable securities
104,755
184,023
Accounts receivable, net
215,394
435,269
Inventories
65,371
136,752
Income tax receivable
26,753
573
Prepaid expenses and other current
assets
31,829
28,656
Total current assets
787,578
1,119,752
Property and equipment, net
78,552
82,756
Operating lease right-of use-assets
65,579
70,225
Goodwill
64,812
64,812
Intangible assets, net
9,668
16,746
Deferred tax assets
26,017
4,111
Other assets
10,269
9,684
Total assets
$
1,042,475
$
1,368,086
Liabilities and Stockholders’
Equity
Current liabilities:
Accounts payable
$
79,726
$
194,626
Accrued liabilities
358,288
513,530
Operating lease liabilities
21,687
23,511
Deferred revenue
32,589
32,307
Income taxes payable
1,448
636
Total current liabilities
493,738
764,610
Long-term deferred revenue
4,626
8,535
Long-term operating lease liabilities
61,410
67,902
Other liabilities
52,385
39,776
Total liabilities
612,159
880,823
Stockholders’ equity:
Class A and Class B common stock
27
26
Additional paid-in capital
1,153,520
1,126,827
Accumulated other comprehensive income
350
188
Accumulated deficit
(723,581)
(639,778)
Total stockholders’ equity
430,316
487,263
Total liabilities and stockholders’
equity
$
1,042,475
$
1,368,086
FITBIT, INC.
Condensed Consolidated
Statements of Cash Flow
(in thousands)
(unaudited)
Three Months Ended
Six Months Ended
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
Cash Flows from Operating
Activities
Net loss
$
(104,097)
$
(68,518)
$
(83,803)
$
(147,983)
Adjustments to reconcile net loss to net
cash used in operating activities:
Provision for doubtful accounts
(441)
16
6,045
48
Provision for excess and obsolete
inventory
3,415
2,644
13,260
4,122
Depreciation
10,453
16,733
21,042
30,106
Non-cash lease expense
6,953
3,902
8,477
11,615
Accelerated depreciation of property and
equipment
613
170
626
170
Amortization of intangible assets
3,049
2,061
7,078
4,121
Stock-based compensation
19,770
20,547
39,497
41,091
Deferred income taxes
(21,865)
154
(21,819)
134
Other
319
212
324
162
Changes in operating assets and
liabilities, net of acquisition:
Accounts receivable
(32,669)
(8,031)
213,830
155,561
Inventories
36,243
9,775
56,544
(41,183)
Prepaid expenses and other assets
22,320
1,862
(5,753)
14,416
Income taxes receivable
113,074
(449)
(26,180)
(409)
Accounts payable
(19,279)
(18,861)
(123,657)
(100,517)
Accrued liabilities and other
liabilities
2,464
(28,048)
(141,269)
(97,964)
Lease liabilities
(6,144)
(8,605)
(10,900)
(13,577)
Deferred revenue
(1,427)
(1,216)
(3,627)
(3,475)
Income taxes payable
(251)
(771)
813
(514)
Net cash provided by (used in)
operating activities
32,500
(76,423)
(49,472)
(144,076)
Cash Flows from Investing
Activities
Purchase of property and equipment
(4,994)
(4,731)
(8,550)
(10,827)
Purchases of marketable securities
—
(108,880)
(59,735)
(220,495)
Sales of marketable securities
—
2,016
—
2,016
Maturities of marketable securities
71,174
111,120
139,365
239,429
Net cash provided by (used in)
investing activities
66,180
(475)
71,080
10,123
Cash Flows from Financing
Activities
Payment of financing lease liability
(1,384)
(340)
(1,384)
(937)
Proceeds from issuance of common stock
544
5,881
1,002
6,812
Taxes paid related to net share settlement
of restricted stock units
(6,361)
(4,227)
(12,229)
(10,649)
Net cash provided by (used in)
financing activities
(7,201)
1,314
(12,611)
(4,774)
Net increase (decrease) in cash and cash
equivalents
91,479
(75,584)
8,997
(138,727)
Cash and cash equivalents at beginning of
period
251,997
410,813
334,479
473,956
Cash and cash equivalents at end of
period
$
343,476
$
335,229
$
343,476
$
335,229
FITBIT, INC.
Reconciliation of GAAP to
Non-GAAP Financial Measures
(in thousands, except percentages
and per share amounts)
(unaudited)
Three Months Ended
Six Months Ended
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
Non-GAAP gross profit:
GAAP gross profit
$
93,042
$
108,214
$
147,964
$
197,667
Stock-based compensation expense
2,033
1,521
4,212
2,951
Impact of restructuring
—
—
—
190
Acquisition-related costs
1,497
—
2,262
—
Intangible assets amortization
1,548
1,853
3,940
3,707
Non-GAAP gross profit
$
98,120
$
111,588
$
158,378
$
204,515
Non-GAAP gross margin (as a percentage
of revenue):
GAAP gross margin
35.6
%
34.5
%
32.9
%
33.8
%
Stock-based compensation expense
0.8
0.5
0.9
0.5
Impact of restructuring
—
—
—
—
Acquisition-related costs
0.6
—
0.5
—
Intangible assets amortization
0.6
0.6
0.9
0.6
Non-GAAP gross margin
37.6
%
35.6
%
35.2
%
34.9
%
Non-GAAP research and
development:
GAAP research and development
$
83,733
$
70,919
$
165,322
$
147,958
Stock-based compensation expense
(11,442)
(11,892)
(22,561)
(23,880)
Impact of restructuring
—
—
—
(1,550)
Acquisition-related costs
(9,653)
—
(15,364)
—
Non-GAAP research and development
$
62,638
$
59,027
$
127,397
$
122,528
Non-GAAP sales and marketing
expense:
GAAP sales and marketing
$
65,470
$
83,060
$
122,431
$
151,676
Stock-based compensation expense
(2,899)
(3,175)
(5,674)
(6,313)
Impact of restructuring
—
—
—
(589)
Acquisition-related costs
(1,836)
—
(4,240)
—
Intangible assets amortization
(1,354)
(136)
(2,797)
(271)
Non-GAAP sales and marketing
$
59,381
$
79,749
$
109,720
$
144,503
Non-GAAP general and administrative
expense:
GAAP general and administrative
$
35,049
$
24,865
$
77,090
$
51,557
Stock-based compensation expense
(3,396)
(3,959)
(7,050)
(7,947)
Impact of restructuring
—
—
—
(129)
Acquisition-related costs
(10,934)
—
(17,826)
—
Intangible assets amortization
(147)
(72)
(341)
(143)
Non-GAAP general and administrative
$
20,572
$
20,834
$
51,873
$
43,338
FITBIT, INC.
Reconciliation of GAAP to
Non-GAAP Financial Measures
(in thousands, except percentages
and per share amounts)
(unaudited)
Three Months Ended
Six Months Ended
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
Non-GAAP operating expenses:
GAAP operating expenses
$
184,252
$
178,844
$
364,843
$
351,191
Stock-based compensation expense
(17,737)
(19,026)
(35,285)
(38,140)
Impact of restructuring
—
—
—
(2,268)
Acquisition-related costs
(22,423)
—
(37,430)
—
Intangible assets amortization
(1,501)
(208)
(3,138)
(414)
Non-GAAP operating expenses
$
142,591
$
159,610
$
288,990
$
310,369
Non-GAAP operating loss and loss before
income taxes:
GAAP operating loss
$
(91,210)
$
(70,630)
$
(216,879)
$
(153,524)
Stock-based compensation expense
19,770
20,547
39,497
41,091
Impact of restructuring
—
—
—
2,458
Acquisition-related costs
23,920
—
39,692
—
Intangible assets amortization
3,049
2,061
7,078
4,121
Non-GAAP operating loss
(44,471)
(48,022)
(130,612)
(105,854)
Interest income, net
13
2,622
1,306
6,088
Other income, net
2,237
461
2,233
1,734
Non-GAAP loss before income taxes
$
(42,221)
$
(44,939)
$
(127,073)
$
(98,032)
Non-GAAP net loss and net loss per
share:
Net loss
$
(104,097)
$
(68,518)
$
(83,803)
$
(147,983)
Stock-based compensation expense
19,770
20,547
39,497
41,091
Impact of restructuring
—
—
—
2,458
Acquisition-related costs
23,920
—
39,692
—
Intangible assets amortization
3,049
2,061
7,078
4,121
Income tax effect of non-GAAP
adjustments
25,832
10,139
(98,582)
26,474
Non-GAAP net loss
$
(31,526)
$
(35,771)
$
(96,118)
$
(73,839)
GAAP diluted shares
267,872
256,160
266,742
254,659
Other dilutive equity awards
—
—
—
—
Non-GAAP diluted shares
267,872
256,160
266,742
254,659
Non-GAAP diluted net loss per share
$
(0.12)
$
(0.14)
$
(0.36)
$
(0.29)
FITBIT, INC.
Reconciliation of GAAP to
Non-GAAP Financial Measures
(in thousands, except percentages
and per share amounts)
(unaudited)
Three Months Ended
Six Months Ended
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
Free cash flow:
Net cash provided by (used in) operating
activities
$
32,500
$
(76,423)
$
(49,472)
$
(144,076)
Purchases of property and equipment
(4,994)
(4,731)
(8,550)
(10,827)
Free cash flow
$
27,506
$
(81,154)
$
(58,022)
$
(154,903)
Net cash provided by (used in) by
investing activities
$
66,180
$
(475)
$
71,080
$
10,123
Net cash provided by (used in) financing
activities
$
(7,201)
$
1,314
$
(12,611)
$
(4,774)
Adjusted EBITDA:
Net loss
$
(104,097)
$
(68,518)
$
(83,803)
$
(147,983)
Stock-based compensation expense
19,770
20,547
39,497
41,091
Impact of restructuring
—
—
—
2,458
Acquisition-related costs
23,920
—
39,692
—
Depreciation and intangible assets
amortization
13,502
18,792
28,120
34,225
Interest expense, net
(13)
(2,622)
(1,306)
(6,088)
Income tax benefit (expense)
15,137
971
(129,537)
2,281
Adjusted EBITDA
$
(31,781)
$
(30,830)
$
(107,337)
$
(74,016)
Stock-based compensation
expense:
Cost of revenue
$
2,033
$
1,521
$
4,212
$
2,951
Research and development
11,442
11,892
22,561
23,880
Sales and marketing
2,899
3,175
5,674
6,313
General and administrative
3,396
3,959
7,050
7,947
Total stock-based compensation expense
$
19,770
$
20,547
$
39,497
$
41,091
FITBIT, INC.
Revenue by Geographic
Region
(in thousands)
(unaudited)
Three Months Ended
Six Months Ended
July 4, 2020
June 29, 2019
July 4, 2020
June 29, 2019
United States
$
164,729
$
180,862
$
266,768
$
315,953
Americas, excluding United States
10,455
19,178
21,198
34,505
Europe, Middle East, and Africa
72,375
87,563
129,381
174,661
Asia Pacific
13,713
25,953
32,083
60,327
Total
$
261,272
$
313,556
$
449,430
$
585,446
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200805005325/en/
Investor Contact:
Tom Hudson, (415) 604-4106 investor@fitbit.com
Media Contact:
Jen Ralls, (415) 722-6937 PR@fitbit.com
Fitbit (NYSE:FIT)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Fitbit (NYSE:FIT)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024